Jason Eric Evans - 20 Jun 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
20 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 16:11:27 UTC
Previous filing
23 May 2025
Next filing
22 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Evans Jason Eric Director C/O TELADOC HEALTH, INC., 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 23 Jun 2025 0001670094

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,016 +17% 7,113 20 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -1,016 -17% $0.000000 5,082 20 Jun 2025 Common Stock 1,016 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On September 20, 2023, the reporting person was granted 12,195 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.